What is the average price target for NOVONIX LTD-ADR (NVX) stock?
5 analysts have analysed NVX and the average price target is 1.43 USD. This implies a price increase of 85.33% is expected in the next year compared to the current price of 0.7742.
NASDAQ:NVX • US67010L1008
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NOVONIX LTD-ADR (NVX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2024-05-30 | Chardan Capital | Initiate | Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 8.055M 4.64% | 5.854M -27.32% | 5.617M -4.05% | 224.92M 3,904.20% | 431.21M 91.72% | 141.55M -67.17% | 192.67M 36.11% | 244.49M 26.90% | |
| EBITDA YoY % growth | N/A -121.64% | N/A 18.76% | N/A 13.96% | -35.805M 41.03% | 31.134M 186.96% | -21.273M -168.33% | -10.284M 51.66% | 1.31M 112.74% | |
| EBIT YoY % growth | -50.079M -15.91% | -54.41M -8.65% | -52.218M 4.03% | -50.905M 2.52% | -1.245M 97.55% | -61.5M -4,838.23% | -52.93M 13.93% | -51.821M 2.09% | |
| Operating Margin | -621.75% | -929.39% | -929.63% | -22.63% | -0.29% | -43.45% | -27.47% | -21.20% | |
| EPS YoY % growth | N/A -99.63% | N/A 16.31% | N/A 26.19% | -0.32 25.00% | -0.11 66.66% | -2.40 -2,152.38% | -2.24 6.64% | -2.24 |
All data in USD
| Q2 / 26 | Q4 / 26 | |
|---|---|---|
| EPS Q2Q % growth | -0.49 -9.46% | -0.38 14.13% |
| Revenue Q2Q % growth | N/A | 149.28M 5,232.19% |
| EBITDA Q2Q % growth | N/A | 3.078M 114.29% |
| EBIT Q2Q % growth | N/A | N/A |
All data in USD
5 analysts have analysed NVX and the average price target is 1.43 USD. This implies a price increase of 85.33% is expected in the next year compared to the current price of 0.7742.
The consensus rating for NOVONIX LTD-ADR (NVX) is 84 / 100 . This indicates that analysts generally have a positive outlook on the stock.